Mutagrip sospensione iniettabile

Country: Switzerland

Language: Italian

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

haemagglutininum influenzae di tipo A (H1N1) (Virus souche Un/Michigan/45/2015 (H1N1)-like: reassortant virus NYMC X-275), haemagglutininum influenzae A (H3N2) (Virus souche A/Hong kong/4801/2014 (H3N2)-come: reassortant virus NYMC X-263B), haemagglutininum influenzae B (Virus souche B/Brisbane/60/2008)

Available from:

Sanofi-Aventis (Suisse) SA

ATC code:

J07BB02

INN (International Name):

haemagglutininum influenzae A (H1N1) (Virus souche A/Michigan/45/2015 (H1N1)-like: reassortant virus NYMC X-275), haemagglutinin

Pharmaceutical form:

sospensione iniettabile

Composition:

haemagglutininum influenzae di tipo A (H1N1) (Virus souche Un/Michigan/45/2015 (H1N1)-like: reassortant virus NYMC X-275) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Hong kong/4801/2014 (H3N2)-come: reassortant virus NYMC X-263B) 15 µg, haemagglutininum influenzae B (Virus souche B/Brisbane/60/2008) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, il resto: formaldehydum max. 100 µg, octoxinolum-9 max. 500 µg, ovalbuminum max. 0,05 µg sintetiche, no, neomycinum nulla, l'acqua ad iniectabilia q.s. la sospensione 0,5 ml.

Therapeutic group:

Vaccini

Therapeutic area:

Immunizzazione attiva contro l'influenza, come già nel 6 ° mese

Authorization date:

1975-09-24